我国医药制造业的区域分工现状分析

Analysis of the Current Situation of Regional Division of Labor in China’s Pharmaceutical Manufacturing Industry

目的:我国医药制造业的发展存在着区域差异,通过分析医药制造业在各省(区、市)的区域分工,了解和把握其分工规律和发展趋势,为构建我国生物医药产业高质量发展的可行路径提供决策依据和可行建议。方法:基于2010-2020年可获得的医药制造业相关指标及数据,从区域经济学角度出发,运用集中度和区位熵等量化指标,分析我国医药制造业的区域分工和集聚情况。结果:2010-2020年京津冀地区、长三角地区、粤港澳大湾区和成渝地区的产业集中度整体表现为增长趋势,呈现出较高程度的产业聚集。东部地区各省份的区位熵整体表现为增长趋势,规模集中度不断提升,区域聚集效应表现较优。中部地区各省份的区位熵表现为相对稳定的发展趋势;西部地区和东北地区的区位熵整体表现为减少趋势。医药制造业未来有望成为江苏省和山东省的二级主导专业化部门,是北京、江西、湖北和四川4省(市)可选择的主导专业化部门。结论:医药制造业已经成为我国部分地区经济发展的支柱产业,其集聚化趋势逐步显现,区域分工呈现东、中、西部差异化。期望通过国家层面的战略规划、顶层设计、制度供给和服务管理,实现我国生物医药产业链分工和专业化发展,促进其高质量发展。

Objective:Based on the regional differences in the development of China’s pharmaceutical manufacturing industry,this paper aims to understand and grasp the rules and development trends of the division of labor of the industry by analyzing the regional division of labor in various provinces and regions,and provide decision-making basis and feasible suggestions for constructing a feasible path for high-quality development of China’s biomedical industry.Methods:Based on the available relevant indicators of the pharmaceutical manufacturing industry from 2010 to 2020 and from the perspective of regional economics,we analyzed the regional division of labor and agglomeration of China’s pharmaceutical manufacturing industry using quantitative indicators such as concentration ration and location quotient.Results:From 2010 to 2020,we observed an overall upward trend in industrial concentration in the Beijing-Tianjin-Hebei region,the Yangtze River Delta region,the Guangdong-Hong Kong-Macao Greater Bay Area,and the Chengdu-Chongqing region,showing a high degree of industrial agglomeration.The overall location entropy and scale concentration in the eastern provinces of China showed an increasing trend,with a relatively good performance of regional agglomeration effect.The location entropy showed a relatively stable development and a decreasing trend in the central provinces of China and in the western and northeastern provinces of China,respectively.The pharmaceutical manufacturing industry is expected to become a secondary leading specialized sector in Jiangsu and Shandong provinces in the future,and is an optional leading specialized sector in Beijing,Jiangxi,Hubei,and Sichuan provinces.Conclusion:The pharmaceutical manufacturing industry has become a pillar industry in the economic development of some regions in China.It has showed a gradually emerging trend of industrial agglomeration,and differentiation of the regional division is obvious in the eastern,central,and western regions.It is expected that China’s biopharmaceutical industry chain division and specialized development can be achieved,and its high-quality development can be promoted through strategic planning,top-level design,system supply,and service management at the national level.